You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – PerkinElmer announced today that the US Food and Drug Administration has cleared its NeoBase 2 Non-Derivatized MSMS kit for testing newborns for metabolic disorders with a single dried blood spot.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.